The use of ligands for histamine H3 receptors (100), hypocretin receptors (101), or TAAR1 receptors (90) for instance, to ameliorate potential cognitive deficits secondary to sleep loss, is a relatively novel and potentially impactful strategy. Here, HRH3 is linked to Cognitive impairment.